Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 18.68
-0.691 %
$ 1.09 B
Market Cap
13.94
P/E
BALANCE SHEET
BALANCE SHEET DECOMPOSITION
Balance Sheet
Embecta Corp.
| Current Assets | 761 M |
| Cash & Short-Term Investments | 268 M |
| Receivables | 248 M |
| Other Current Assets | 246 M |
| Non-Current Assets | 524 M |
| Long-Term Investments | 0 |
| PP&E | 290 M |
| Other Non-Current Assets | 234 M |
| Current Liabilities | 374 M |
| Accounts Payable | 91 M |
| Short-Term Debt | 12.9 M |
| Other Current Liabilities | 270 M |
| Non-Current Liabilities | 1.65 B |
| Long-Term Debt | 1.6 B |
| Other Non-Current Liabilities | 54.1 M |
Balance Sheet
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 267.5 | 326.5 | 330.9 | 0 | 0 | 0 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 248.0 | 17.9 | 23.4 | 150.6 | 120.0 | 127.0 |
| Inventory | 171.5 | 152.1 | 122.8 | 118.0 | 102.0 | 101.0 |
| Other Current Assets | 74.0 | 252.6 | 187.6 | 21.8 | 13.0 | 20.0 |
| Total Current Assets | 761.0 | 749.1 | 664.7 | 292.0 | 235.0 | 248.0 |
| PP&E | 290.4 | 323.2 | 301.6 | 451.0 | 462.0 | 457.0 |
| Intangible Assets | 8.1 | 9.1 | 8.9 | 18.0 | 14.0 | 16.0 |
| Goodwill | 15.6 | 15.6 | 15.7 | 16.0 | 16.0 | 16.0 |
| Long Term Investments | 0 | 0 | (95.5) | (11.4) | 0 | 0 |
| Other Long Term Assets | 210.2 | 117.4 | 95.5 | 11.0 | 11.0 | 8.0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 285.3 | 1 214.4 | 1 086.4 | 788.0 | 738.0 | 745.0 |
| LIABILITIES | ||||||
| Accounts Payable | 91.0 | 53.5 | 41.4 | 54.2 | 50.0 | 47.0 |
| Short Term Debt | 12.9 | 13.1 | 13.1 | 0 | 0 | 0 |
| Other Current Liabilities | 243.4 | 253.3 | 219.3 | 109.8 | 87.0 | 79.0 |
| Total Current Liabilities | 374.0 | 353.5 | 301.0 | 164.0 | 137.0 | 126.0 |
| Long Term Debt | 1 595.5 | 1 640.8 | 1 635.0 | 6.0 | 8.0 | 0 |
| Deferred Tax Income | 11.9 | 0 | 46.1 | 30.0 | 29.0 | 0 |
| Other Liabilities | 42.2 | 41.8 | (4.3) | (6.0) | (8.0) | 0 |
| Total Liabilities | 2 023.6 | 2 036.1 | 1 977.8 | 194.0 | 166.0 | 126.0 |
| EQUITY | ||||||
| Common Stock | 0.6 | 0.6 | 0.6 | 865.0 | 834.0 | 855.0 |
| Retained Earnings | (498.6) | (541.1) | (577.1) | 0 | 0 | 0 |
| Other Accumulative Comprehensive Income/Loss | (292.8) | (309.1) | (324.9) | (271.0) | (262.0) | (278.0) |
| Total Equity | (738.3) | (821.7) | (891.4) | 594.0 | 572.0 | 577.0 |
| Total Liabilities and Equity | 1 285.3 | 1 214.4 | 1 086.4 | 788.0 | 738.0 | 703.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 0 | 57.2 | 57.1 | 56.8 | 57.0 | 57.0 |